Cost-Effective Stepwise Algorithm for Screening Iron Deficiency Anemia in High-Risk Populations
For high-risk populations, begin with serum ferritin as the initial screening test using population-specific thresholds: ≤30 ng/mL for menstruating individuals and pregnant women, ≤50 ng/mL for adults generally, and reserve CBC for cases where ferritin is equivocal or when anemia needs confirmation. 1
Initial Screening Approach
The most recent ASH 2026 guidelines 1 and Lancet Haematology 2025 consensus 2 establish ferritin as the superior first-line test based on diagnostic performance, moving away from older strategies that relied on CBC parameters first.
Step 1: Serum Ferritin First
Start with ferritin measurement using these diagnostic thresholds:
Menstruating individuals: ≤30 ng/mL (strong recommendation) 1
- Consider ≤50 ng/mL threshold for those with anemia, heavy menstrual bleeding, or significant symptoms
Pregnant individuals: ≤30 ng/mL (conditional recommendation) 1
- Use ≤50 ng/mL threshold if anemia present or other risk factors exist
- Note: Ferritin >70 ng/mL protects against developing iron deficiency throughout gestation 2
General adults: <50 ng/mL as starting point 2
Adults with cancer: <100 ng/mL for absolute iron deficiency 2
Step 2: When to Add CBC
Order CBC in these specific scenarios:
- When ferritin is borderline (between 15-50 ng/mL depending on population) to assess for microcytosis and confirm anemia
- When inflammation is suspected (ferritin can be falsely elevated as an acute phase reactant)
- To differentiate IDA from other causes of microcytosis, particularly thalassemia trait
- When ferritin testing is unavailable or cost-prohibitive
The older research 3, 4 suggested starting with transferrin saturation and TIBC, but this approach has been superseded by current guidelines prioritizing ferritin for its superior diagnostic accuracy.
Cost-Effectiveness Rationale
Why ferritin first is most cost-effective:
- Single test with high diagnostic accuracy eliminates need for multiple initial tests 2, 1
- Prevents the 93-96% of cases that would require ferritin anyway after equivocal CBC results 3, 4
- CBC discrimination indices (Mentzer, RDW, etc.) show poor specificity (6.7-35.3%) for distinguishing iron-deficient from non-iron-deficient microcytosis 5
- Machine learning models using CBC parameters alone achieve only modest performance (AUC 0.80-0.87) compared to direct ferritin measurement 6
Algorithm for Equivocal Cases
When ferritin results are inconclusive (15-50 ng/mL range):
Check for inflammation markers (CRP, ESR) - inflammation falsely elevates ferritin 2
If still uncertain, consider transferrin saturation:
Time-limited therapeutic trial: If tests remain inconclusive, empiric iron therapy for 4-8 weeks with reassessment may be most cost-effective 2, 7
Critical Pitfalls to Avoid
Common diagnostic errors:
- Don't use hemoglobin alone - multiple guidelines explicitly recommend against this 2
- Don't rely on WHO cutoffs (<12 ng/mL children <5 years, <15 ng/mL older children) - these are too low and miss significant iron deficiency 2
- Don't use CBC indices as standalone screening - they have unacceptably high false-positive rates 5
- Don't ignore inflammation - ferritin >50 ng/mL can still represent iron deficiency in inflammatory states 2
Population-Specific Modifications
High-risk groups requiring adjusted approach:
- Inflammatory bowel disease: Consider intravenous iron first-line regardless of ferritin, as oral absorption is impaired 2
- Post-bariatric surgery: Lower threshold for diagnosis due to malabsorption 2
- Adult men and postmenopausal women with IDA: Mandate bidirectional endoscopy to identify GI bleeding sources 2
When Screening Questionnaires Add Value
For resource-limited settings screening young women, the IRON-5 questionnaire (non-omnivorous diet, heavy menstruation, activity avoidance during menses, no iron supplementation, no hormonal contraceptives) with score ≥3 achieves 74% sensitivity and can prioritize who gets blood testing 8. However, this is an adjunct to, not replacement for, ferritin measurement.
The evidence strongly supports ferritin-first strategy over older CBC-first or transferrin saturation-first approaches, with CBC reserved for confirmation and differential diagnosis rather than initial screening. 2, 1